SECONDARY HYPERPARATHYROIDISM AMONG END-STAGE RENAL DISEASE PATIENTS
نویسندگان
چکیده
منابع مشابه
The role of secondary hyperparathyroidism in anemia of end stage renal disease
Introduction: secondary hyperparathyroidism is listed among the possible reasons for intensifying the anemia and resistance to erythropoietin therapy in hemodialysis patients. Although its exact mechanism is not entirely clarified, but shift of bone marrow cells to adipocytes, bone marrow fibrosis and decreased calciteriol can be the causes. However, the role of secondary hyperparathyroidism in...
متن کاملCalcimimetic agents in the management of secondary hyperparathyroidism among patients with end-stage renal disease; a review article
Introduction End-stage renal disease (ESRD) is one of the most common life-threatening diseases with significant complication and poor outcomes (1-8). Possibly because of increasing prevalence of obesity, diabetes and hypertension, the number of ESRD patients increases each year and imposes a major social and economic burden on countries (9,10). Secondary hyperparathyroidism (SHPT) is a wellrec...
متن کاملUtilization of parathyroidectomy for secondary hyperparathyroidism in end-stage renal disease
BACKGROUND The utilization of parathyroidectomy (PTX) to manage secondary hyperparathyroidism (SHPT) refractory to medical management (MTX) in end-stage renal disease (ESRD) in the era of calcimimetics is not well known. METHODS Adult ESRD patients receiving dialysis between August 2007 and December 2011 at our institution with an intact parathyroid hormone (iPTH) level ≥88 pmol/L for 6 month...
متن کاملMassive soft tissue calcifications in severe hyperparathyroidism secondary to end-stage renal disease.
191 A 57‐year‐old woman with chronic kidney disease (CKD) on hemodialysis for 5 years underwent sub‐ total parathyroidectomy for secondary hyperpara‐ thyroidism. Three years later, she presented with gradually increasing serum parathormone (abo‐ ve 1000 pg/ml) and phosphate levels despite tre‐ atment with high doses of phosphate binders with active vitamin D metabolites. Simultaneously, bone pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Innovare Journal of Medical Sciences
سال: 2020
ISSN: 2321-4406
DOI: 10.22159/ijms.2020.v8i6.39598